UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Obesity in adults: Prevalence, screening, and evaluation

Authors
George A Bray, MD
Leigh Perreault, MD
Section Editor
F Xavier Pi-Sunyer, MD, MPH
Deputy Editor
Kathryn A Martin, MD

INTRODUCTION

The morbidity and mortality associated with being overweight (body mass index [BMI] of 25 to 29.9 kg/m2) or obese (BMI of ≥30 kg/m2) have been known to the medical profession for more than 2000 years [1]. Obesity is a chronic disease that is increasing in prevalence in adults, adolescents, and children and is now considered to be a global epidemic. Screening for obesity can identify high-risk patients who may not otherwise receive counseling about health risks, lifestyle changes, obesity treatment options, and risk factor reduction. Evaluation of an overweight or obese patient should include both clinical and laboratory studies; the combined information is used to characterize the type and severity of obesity, determine health risk, and provide a basis for selecting therapy.

The prevalence of obesity, the approach to screening, and the clinical evaluation of obesity in adults will be reviewed here. The health risks associated with obesity and approach to treatment are discussed in detail separately. (See "Obesity in adults: Health hazards" and "Obesity in adults: Overview of management".)

PREVALENCE

Obesity is a chronic disease that is increasing in prevalence around the world. Estimates of obesity prevalence in the United States using consistent, standardized methods have been ongoing since 1960 [2,3]. Prevalence data have been collected in two ways: annual telephone surveys conducted by state Departments of Health in collaboration with the Centers for Disease Control and Prevention in Atlanta, GA (the Behavioral Risk Factor Surveillance System [BRFSS]) and direct measurement of height and weight in field surveys by the National Center for Health Statistics as the National Health and Nutrition Examination Survey (NHANES).

Data from BRFSS, the telephone survey, reported a prevalence that was approximately two-thirds that of the NHANES surveys. This could be because people underreport their weight, overreport their height, or both during the telephone surveys. Thus, when reading literature on prevalence of overweight and obesity, it is important to identify which survey was used.

United States

Behavioral risk factor (telephone) survey — The prevalence of obesity obtained by self-report in the United States in 2014 was 28.9 percent, ranging from 20.2 percent in Colorado to 36.2 percent in Louisiana [4]. The prevalence was higher in the Midwest and the South and lower in the Northeast and the West. Although there was a dramatic increase in obesity rates between 1990 and 2010, rates appear to be stabilizing. The self-reported prevalence of obesity by region generally parallels the results obtained by more rigorous objective surveys, but the self-reported prevalences are lower [5].

                 

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Sep 26 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Bray GA. The Battle of the Bulge: A History of Obesity Research, Dorrance, Pittsburgh 2007.
  2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723.
  3. Ljungvall A, Zimmerman FJ. Bigger bodies: long-term trends and disparities in obesity and body-mass index among U.S. adults, 1960-2008. Soc Sci Med 2012; 75:109.
  4. https://nccd.cdc.gov/NPAO_DTM/LocationSummary.aspx?statecode=94.
  5. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307:491.
  6. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311:806.
  7. Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA 2016; 315:2284.
  8. Katzmarzyk PT. The Canadian obesity epidemic, 1985-1998. CMAJ 2002; 166:1039.
  9. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766.
  10. Johnson F, Cooke L, Croker H, Wardle J. Changing perceptions of weight in Great Britain: comparison of two population surveys. BMJ 2008; 337:a494.
  11. International Association for the Study of Obesity http://www.iaso.org/resources/world-map-obesity/ (Accessed on February 06, 2014).
  12. http://vizhub.healthdata.org/obesity/ (Accessed on September 12, 2016).
  13. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009; 28:w822.
  14. Bardia A, Holtan SG, Slezak JM, Thompson WG. Diagnosis of obesity by primary care physicians and impact on obesity management. Mayo Clin Proc 2007; 82:927.
  15. Gallagher D, Visser M, Sepúlveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143:228.
  16. Mei Z, Grummer-Strawn LM, Pietrobelli A, et al. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 2002; 75:978.
  17. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373:1083.
  18. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2:51S.
  19. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i.
  20. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22:1164.
  21. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115:2111.
  22. Hsu WC, Araneta MR, Kanaya AM, et al. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care 2015; 38:150.
  23. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129:S102.
  24. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004; 79:379.
  25. Simpson JA, MacInnis RJ, Peeters A, et al. A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity (Silver Spring) 2007; 15:994.
  26. Koster A, Leitzmann MF, Schatzkin A, et al. Waist circumference and mortality. Am J Epidemiol 2008; 167:1465.
  27. Jacobs EJ, Newton CC, Wang Y, et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 2010; 170:1293.
  28. Tsai AG, Wadden TA. In the clinic: obesity. Ann Intern Med 2013; 159:ITC3.
  29. Gallagher D, Heymsfield SB, Heo M, et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72:694.
  30. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf (Accessed on January 23, 2013).
  31. Lau DC, Obesity Canada Clinical Practice Guidelines Steering Committee and Expert Panel. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 2007; 176:1103.
  32. Lyznicki JM, Young DC, Riggs JA, et al. Obesity: assessment and management in primary care. Am Fam Physician 2001; 63:2185.
  33. Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:373.
  34. ACOG Committee on Gynecologic Practice. ACOG committee opinion. Number 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity. Obstet Gynecol 2005; 106:895.
  35. Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004; 350:865.
  36. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341:427.